• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

别构位点结合调节免疫调节酶ScpA的特异性,ScpA是一种使C5a失活的细菌蛋白酶。

Exosite binding modulates the specificity of the immunomodulatory enzyme ScpA, a C5a inactivating bacterial protease.

作者信息

Jain Monica, Teçza Malgorzata, Kagawa Todd F, Cooney Jakki C

机构信息

Department of Biological Sciences, University of Limerick, Limerick, Ireland.

Department of Chemical Sciences, University of Limerick, Limerick, Ireland.

出版信息

Comput Struct Biotechnol J. 2022 Aug 27;20:4860-4869. doi: 10.1016/j.csbj.2022.08.018. eCollection 2022.

DOI:10.1016/j.csbj.2022.08.018
PMID:36147677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9464890/
Abstract

The C5a peptidase from (ScpA) is a highly specific enzyme with potential therapeutic value. ScpA is a good model for studying determinants of specificity in the multidomain immunomodulatory enzymes (IMEs), which comprise a large family of bacterial surface proteases. The surface exposed region of ScpA has 5 main domains which includes 3 C-terminal Fn3-like domains (Fn1, Fn2 and Fn3) (Kagawa et al. 2009). Progressive deletion of the Fn3-like domains from the C-ter resulted in loss of enzyme activity and showed an important role for the Fn2 domain in enzyme function. Functional investigation of specific acidic residues on the Fn2 domain identified 3 residues 30-50 Å from the catalytic site (D783, E864 and D889) which impacted to differing degrees on binding and on catalysis, supporting the presence of an exosite on the Fn2. In particular, residue D783 was observed to impact on both substrate binding affinity and the activity of ScpA. A double mutant cycle analysis showed energetic coupling between the targeted ScpA residues and residues in the core portion (residues 1-67) of the C5a substrate. The data supports the presence of a communication network between the active site and the exosite on Fn2. These findings provide a basis for rational engineering of this important enzyme family to enhance stability, activity and/or specificity.

摘要

来自[具体物种未提及]的C5a肽酶(ScpA)是一种具有潜在治疗价值的高度特异性酶。ScpA是研究多结构域免疫调节酶(IME)特异性决定因素的良好模型,IME是一大类细菌表面蛋白酶。ScpA的表面暴露区域有5个主要结构域,包括3个C端Fn3样结构域(Fn1、Fn2和Fn3)(Kagawa等人,2009年)。从C端逐步缺失Fn3样结构域会导致酶活性丧失,并表明Fn2结构域在酶功能中起重要作用。对Fn2结构域上特定酸性残基的功能研究确定了3个距离催化位点30 - 50 Å的残基(D783、E864和D889),它们对结合和催化有不同程度的影响,支持Fn2上存在一个别构位点。特别是,观察到残基D783会影响底物结合亲和力和ScpA的活性。双突变循环分析表明,靶向的ScpA残基与C5a底物核心部分(残基1 - 67)中的残基之间存在能量耦合。这些数据支持活性位点与Fn2上的别构位点之间存在通信网络。这些发现为合理改造这一重要酶家族以提高稳定性、活性和/或特异性提供了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/39964f7b23a5/fx6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/03e22fe92df7/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/07e2a4606781/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/dcdf38ea309c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/fe34f12bfbae/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/f8fb7bca3ed3/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/c4248478a191/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/4e0f2cbbc911/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/e605c759002b/fx2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/96940e1a7152/fx3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/e992f5a7a2b7/fx4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/6dae67c1acf2/fx5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/39964f7b23a5/fx6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/03e22fe92df7/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/07e2a4606781/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/dcdf38ea309c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/fe34f12bfbae/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/f8fb7bca3ed3/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/c4248478a191/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/4e0f2cbbc911/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/e605c759002b/fx2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/96940e1a7152/fx3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/e992f5a7a2b7/fx4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/6dae67c1acf2/fx5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc2/9464890/39964f7b23a5/fx6.jpg

相似文献

1
Exosite binding modulates the specificity of the immunomodulatory enzyme ScpA, a C5a inactivating bacterial protease.别构位点结合调节免疫调节酶ScpA的特异性,ScpA是一种使C5a失活的细菌蛋白酶。
Comput Struct Biotechnol J. 2022 Aug 27;20:4860-4869. doi: 10.1016/j.csbj.2022.08.018. eCollection 2022.
2
Model for substrate interactions in C5a peptidase from Streptococcus pyogenes: A 1.9 A crystal structure of the active form of ScpA.化脓性链球菌C5a肽酶中底物相互作用模型:ScpA活性形式的1.9埃晶体结构
J Mol Biol. 2009 Feb 27;386(3):754-72. doi: 10.1016/j.jmb.2008.12.074. Epub 2009 Jan 6.
3
X-ray diffraction data for the C5a-peptidase mutant with modified activity and specificity.具有修饰活性和特异性的C5a肽酶突变体的X射线衍射数据。
Data Brief. 2022 Nov 23;46:108778. doi: 10.1016/j.dib.2022.108778. eCollection 2023 Feb.
4
Enzyme kinetic and binding studies identify determinants of specificity for the immunomodulatory enzyme ScpA, a C5a inactivating bacterial protease.酶动力学和结合研究确定了免疫调节酶ScpA(一种C5a失活细菌蛋白酶)特异性的决定因素。
Comput Struct Biotechnol J. 2021;19:2356-2365. doi: 10.1016/j.csbj.2021.04.024. Epub 2021 Apr 17.
5
The protease associated (PA) domain in ScpA from Streptococcus pyogenes plays a role in substrate recruitment.来自酿脓链球菌的 ScpA 中的蛋白酶相关 (PA) 结构域在底物募集中发挥作用。
Biochim Biophys Acta Proteins Proteom. 2023 Nov 1;1871(6):140946. doi: 10.1016/j.bbapap.2023.140946. Epub 2023 Aug 9.
6
The 1.7 Å crystal structure of the C5a peptidase from Streptococcus agalactiae (ScpB) reveals an active site competent for catalysis.1.7Å 分辨率的酿脓链球菌 C5a 肽酶(ScpB)晶体结构揭示了一个具有催化能力的活性位点。
Proteins. 2024 Mar;92(3):427-431. doi: 10.1002/prot.26625. Epub 2023 Nov 3.
7
Impact of Propeptide Cleavage on the Stability and Activity of a Streptococcal Immunomodulatory C5a Peptidase for Biopharmaceutical Development.原肽切割对用于生物制药开发的链球菌免疫调节 C5a 肽酶的稳定性和活性的影响。
Mol Pharm. 2023 Aug 7;20(8):4041-4049. doi: 10.1021/acs.molpharmaceut.3c00207. Epub 2023 Jul 5.
8
C5a peptidase (ScpA) activity towards human type II and type III interferons.C5a 肽酶(ScpA)对人 II 型和 III 型干扰素的活性。
Cytokine. 2024 Aug;180:156652. doi: 10.1016/j.cyto.2024.156652. Epub 2024 May 17.
9
Multi-functional mechanisms of immune evasion by the streptococcal complement inhibitor C5a peptidase.链球菌补体抑制剂C5a肽酶的多功能免疫逃逸机制
PLoS Pathog. 2017 Aug 14;13(8):e1006493. doi: 10.1371/journal.ppat.1006493. eCollection 2017 Aug.
10
Characterization of the streptococcal C5a peptidase using a C5a-green fluorescent protein fusion protein substrate.使用C5a-绿色荧光蛋白融合蛋白底物对链球菌C5a肽酶进行表征。
J Bacteriol. 2000 Jun;182(11):3254-8. doi: 10.1128/JB.182.11.3254-3258.2000.

引用本文的文献

1
The life-and-death struggle between the complement system and pathogens: Mechanisms of elimination, evasion tactics, and translational potential.补体系统与病原体之间的生死较量:清除机制、逃避策略及转化潜力
Virulence. 2025 Dec;16(1):2553781. doi: 10.1080/21505594.2025.2553781. Epub 2025 Sep 4.
2
: Pathogenesis and the Current Status of Vaccines.发病机制与疫苗的现状
Vaccines (Basel). 2023 Sep 21;11(9):1510. doi: 10.3390/vaccines11091510.
3
X-ray diffraction data for the C5a-peptidase mutant with modified activity and specificity.

本文引用的文献

1
Persistence of High Levels of Serum Complement C5a in Severe COVID-19 Cases After Hospital Discharge.出院后严重 COVID-19 病例血清补体 C5a 水平持续升高。
Front Immunol. 2021 Nov 18;12:767376. doi: 10.3389/fimmu.2021.767376. eCollection 2021.
2
The Role of Streptococcal Cell-Envelope Proteases in Bacterial Evasion of the Innate Immune System.链球菌细胞包膜蛋白酶在细菌逃避固有免疫系统中的作用。
J Innate Immun. 2022;14(2):69-88. doi: 10.1159/000516956. Epub 2021 Oct 14.
3
Enzyme kinetic and binding studies identify determinants of specificity for the immunomodulatory enzyme ScpA, a C5a inactivating bacterial protease.
具有修饰活性和特异性的C5a肽酶突变体的X射线衍射数据。
Data Brief. 2022 Nov 23;46:108778. doi: 10.1016/j.dib.2022.108778. eCollection 2023 Feb.
酶动力学和结合研究确定了免疫调节酶ScpA(一种C5a失活细菌蛋白酶)特异性的决定因素。
Comput Struct Biotechnol J. 2021;19:2356-2365. doi: 10.1016/j.csbj.2021.04.024. Epub 2021 Apr 17.
4
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.补体系统的治疗靶向:从罕见病到流行病。
Pharmacol Rev. 2021 Apr;73(2):792-827. doi: 10.1124/pharmrev.120.000072.
5
Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes.补体系统在 2019 年冠状病毒病病程中的作用及其对临床结局的影响。
J Infect Dis. 2021 Feb 3;223(2):214-224. doi: 10.1093/infdis/jiaa646.
6
Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial.抗C5a抗体IFX-1(vilobelimab)治疗与最佳支持治疗对重症COVID-19患者的疗效比较(PANAMO):一项探索性、开放标签的2期随机对照试验。
Lancet Rheumatol. 2020 Dec;2(12):e764-e773. doi: 10.1016/S2665-9913(20)30341-6. Epub 2020 Sep 28.
7
Supertertiary protein structure affects an allosteric network.超三级蛋白质结构影响变构网络。
Proc Natl Acad Sci U S A. 2020 Sep 29;117(39):24294-24304. doi: 10.1073/pnas.2007201117. Epub 2020 Sep 14.
8
Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.COVID-19 炎症与 C5a-C5aR1 轴的激活有关。
Nature. 2020 Dec;588(7836):146-150. doi: 10.1038/s41586-020-2600-6. Epub 2020 Jul 29.
9
Structure, dynamics and immunogenicity of a catalytically inactive CC chemokine-degrading protease SpyCEP from .来自……的催化失活的CC趋化因子降解蛋白酶SpyCEP的结构、动力学和免疫原性
Comput Struct Biotechnol J. 2020 Mar 13;18:650-660. doi: 10.1016/j.csbj.2020.03.004. eCollection 2020.
10
Multi-functional mechanisms of immune evasion by the streptococcal complement inhibitor C5a peptidase.链球菌补体抑制剂C5a肽酶的多功能免疫逃逸机制
PLoS Pathog. 2017 Aug 14;13(8):e1006493. doi: 10.1371/journal.ppat.1006493. eCollection 2017 Aug.